Vitamin B3 deficiency (pellagra) has a defined treatment pathway, but specific clinical situations arise where standard treatment methods cannot be applied. A structured alternative approach exists for these cases, governed by particular conditions and important safety considerations.
When standard treatment options are not available, an alternative involving a specific amino acid precursor may be considered. The full protocol outlines the precise clinical criteria, safety conditions, and monitoring requirements that must be in place before this approach is used.
DOI: 10.24425/fmc.2021.138956